1. Home
  2. EW

as 06-18-2024 9:30am EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Industrial Specialties

Nasdaq

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Founded: 1958 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 52.6B IPO Year: 2000
Target Price: $94.79 AVG Volume (30 days): 2.4M
Analyst Decision: Buy Number of Analysts: 20
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.32 EPS Growth: -3.73
52 Week Low/High: $60.57 - $96.12 Next Earning Date: 07-24-2024
Revenue: $6,143,400,000 Revenue Growth: 11.68%
Revenue Growth (this year): 12.56% Revenue Growth (next year): 9.78%

EW Daily Stock ML Predictions

Stock Insider Trading Activity of Edwards Lifesciences Corporation (EW)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer May 21 '24 Sell $90.45 5,625 $508,803.19 30,561 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Apr 30 '24 Sell $86.40 700 $60,482.52 25,624 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Apr 30 '24 Sell $85.74 6,550 $561,579.32 19,074 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Apr 1 '24 Sell $95.51 868 $82,902.68 25,461 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Apr 1 '24 Sell $94.81 6,387 $605,520.81 19,074 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Feb 29 '24 Sell $85.59 7,255 $620,922.80 19,074 SEC Form 4
GALLAHUE KIERAN EW Director Feb 23 '24 Sell $87.61 3,058 $267,911.38 67,219 SEC Form 4
Chopra Daveen EW CVP, TMTT Feb 21 '24 Sell $86.67 1,200 $104,004.24 29,750 SEC Form 4
Chopra Daveen EW CVP, TMTT Feb 21 '24 Sell $86.75 7,000 $607,267.50 22,750 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Feb 1 '24 Sell $78.29 7,255 $567,993.95 19,248 SEC Form 4
Ullem Scott B. EW CVP, Chief Financial Officer Dec 29 '23 Sell $76.55 14,510 $1,110,794.19 19,248 SEC Form 4
Chopra Daveen EW CVP, TMTT Dec 15 '23 Sell $78.25 7,000 $547,724.10 23,950 SEC Form 4
Chopra Daveen EW CVP, TMTT Dec 6 '23 Sell $70.00 3,500 $245,005.60 23,950 SEC Form 4

Share on Social Networks: